Latest News & Updates
Breaking News
22 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Teva and Medincell Secure EMA Filing Acceptance for TEV-749 Long-Acting Schizophrenia Injectable
EMA accepts TEV-749 marketing application from Teva and Medincell, advancing a BEPO-platform subcutaneous LAI for schizophrenia into full centralised review.
Pharma Now Editorial Team
Anupam Rasayan Acquires 43.3–48.2% Stake in Bliss GVS Pharma in Vertical Integration Move
Anupam Rasayan acquires a 43.3–48.2% stake in Bliss GVS Pharma, raising GMP alignment and regulatory integration questions for the combined entity.
Pharma Now Editorial Team
AbbVie Gains EU Committee Backing for MAVIRET Expansion into Acute Hepatitis C Indication
AbbVie's MAVIRET receives CHMP positive opinion for acute HCV, potentially creating one of the EU's few dual acute/chronic hepatitis C labels.
Pharma Now Editorial Team
Lilly's Foundayo Achieves Significant Weight Reduction in Seniors Across All Doses at 72 Weeks
Lilly's Foundayo hit statistically significant weight loss across all doses at 72 weeks, raising CMC and scale-up stakes for oral GLP-1 competitors.
Pharma Now Editorial Team
